Belite Bio, Inc

Belite Bio, Incverified

BLTE

Price:

$151.27

Market Cap:

$5.28B

Belite Bio, Inc, a clinical-stage biopharmaceutical drug development company, engages in the research and development of novel therapeutics targeting atrophic age-related macular degeneration and autosomal recessive stargardt diseases. Its lead product candidate is LBS-008, an oral once-a-day treatment that can reduce and maintain the delivery of vitamin A to the eye to reduce the accumulation of toxic vitamin A by-products in ocular tissue that is in phase 3 clinical trial. The company is also developing LBS-009, an anti-retinol binding protein 4 oral therapy targeting liver disease, including non-alcoholic fatty liver disease, nonalcoholic steatohepatitis, and type 2 diabetes, which is in ...[Read more]

Industry

Biotechnology

IPO Date

2022-04-29

Stock Exchange

NASDAQ

Ticker

BLTE

The PE Ratio as of December 2025 (TTM) for Belite Bio, Inc (BLTE) is -79.20

According to Belite Bio, Inc’s latest financial reports and current stock price. The company's current PE Ratio is -79.20. This represents a change of 102.34% compared to the average of -39.14 of the last 4 quarters.

Belite Bio, Inc (BLTE) Historical PE Ratio (quarterly & annually)

How has BLTE PE Ratio performed in the past?

The mean historical PE Ratio of Belite Bio, Inc over the last ten years is -36.55. The current -79.20 PE Ratio has changed 21.57% with respect to the historical average. Over the past ten years (40 quarters), BLTE's PE Ratio was at its highest in in the September 2021 quarter at -10.25. The PE Ratio was at its lowest in in the September 2022 quarter at -86.80.

Quarterly (TTM)
Annual

Average

-36.55

Median

-38.46

Minimum

-53.31

Maximum

-16.95

Belite Bio, Inc (BLTE) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Belite Bio, Inc PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 80.36%

Maximum Annual PE Ratio = -16.95

Minimum Annual Increase = -19.22%

Minimum Annual PE Ratio = -53.31

Quarterly (TTM)
Annual
YearPE RatioChange
2024-53.3138.61%
2023-38.46-19.22%
2022-47.6180.36%
2021-26.4055.78%

Belite Bio, Inc (BLTE) Average PE Ratio

How has BLTE PE Ratio performed in the past?

The current PE Ratio of Belite Bio, Inc (BLTE) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

-46.46

5-year avg

-36.55

10-year avg

-36.55

Belite Bio, Inc (BLTE) PE Ratio vs. Peers

How is BLTE’s PE Ratio compared to its peers?

Belite Bio, Inc’s PE Ratio is greater than Mirum Pharmaceuticals, Inc. (-87.44), less than Ligand Pharmaceuticals Incorporated (101.89), less than ADMA Biologics, Inc. (23.24), less than Praxis Precision Medicines, Inc. (-16.25), less than ACADIA Pharmaceuticals Inc. (20.06), less than Soleno Therapeutics, Inc. (-35.81), less than Dyne Therapeutics, Inc. (-5.70), greater than Arcutis Biotherapeutics, Inc. (-89.72), less than Viking Therapeutics, Inc. (-18.25), less than Crinetics Pharmaceuticals, Inc. (-10.56),

Build a custom stock screener for Belite Bio, Inc (BLTE) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Belite Bio, Inc using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Belite Bio, Inc (BLTE) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Belite Bio, Inc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Belite Bio, Inc's PE Ratio?

How is the PE Ratio calculated for Belite Bio, Inc (BLTE)?

What is the highest PE Ratio for Belite Bio, Inc (BLTE)?

What is the 3-year average PE Ratio for Belite Bio, Inc (BLTE)?

What is the 5-year average PE Ratio for Belite Bio, Inc (BLTE)?

How does the current PE Ratio for Belite Bio, Inc (BLTE) compare to its historical average?